Implications of Intravenous and Inhaled Amikacin Breakpoint Reporting for <i>Mycobacterium avium</i> Complex Pulmonary Isolates
The treatment of <i>Mycobacterium avium</i> complex (MAC) remains a clinical challenge as multidrug regimens are needed and may be limited by treatment-related toxicity. The Clinical and Laboratory Standards Institute (CLSI) endorses breakpoints for several agents used for MAC infection...
Saved in:
Main Authors: | Christian M. Gill, Robin Chamberland, Getahun Abate |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/14/6/583 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunity Against <i>Mycobacterium avium</i> Induced by DAR-901 and BCG
by: Getahun Abate, et al.
Published: (2025-06-01) -
Oxidative Stress and Apoptotic Markers in Goats Naturally Infected with <i>Mycobacterium avium</i> subsp. <i>paratuberculosis</i>
by: Merve Ozturk, et al.
Published: (2025-06-01) -
Investigation of WQ-3810, a Fluoroquinolone with a High Potential Against Fluoroquinolone-Resistant <i>Mycobacterium avium</i>
by: Sasini Jayaweera, et al.
Published: (2025-07-01) -
<i>M. avium Complex</i> Pulmonary Infections: Therapeutic Obstacles and Progress in Drug Development
by: Elise Si Ahmed Charrier, et al.
Published: (2025-06-01) -
Dual Antibiotic-Infused Liposomes to Control Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Sourav Chakraborty, et al.
Published: (2025-05-01)